Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Sebesta has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations Between FGF8, FGF18, and FGFR4 Expression and Immune Checkpoint Markers PD-1 and PD-L1 in Adenocarcinoma of the Gastroesophageal Junction (AEG)

    by Gerd Jomrich, Winny Yan, Dagmar Kollmann, Ivan Kristo, Daniel Winkler, Hannah Puhr, Aysegül Ilhan-Mutlu, Marlene Hollenstein, Reza Asari, Christian Sebesta, et al.

    Background: Adenocarcinoma of the esophagogastric junction (AEG) remains a highly lethal disease despite multimodal therapy. The interplay between fibroblast growth factor (FGF) signaling and immune-checkpoint regulation in AEG is poorly understood. This study investigated the associations between FGF8, FGF18, and FGFR4 expression and PD-1/PD-L1/PD-L2 expression. Methods: In a cohort of 117 resected AEG cases, immunohistochemical expression of FGF8, FGF18, PD-1, PD-L1, and PD-L2 was analyzed. Associations were assessed using chi-square tests and Pearson correlation analyses. Combined FGF8–FGF18 expression groups and survival outcomes were evaluated using Kaplan–Meier analysis. Results: The updated correlation analysis included 107 cases and identified a weak inverse association between FGF8 expression and PD-L1 expression in tumor cells (r = −0.175, p = 0.036). No statistically significant correlations were observed between FGF18 expression and the investigated immune-checkpoint markers. Clinically, FGF18 was associated with advanced pT stage (p < 0.001) and postoperative UICC classification (p = 0.005), while both FGF8 (p = 0.022) and FGF18 (p = 0.015) were associated with lymph node metastasis. In the combined FGF8–FGF18 analysis, PD-1-negative lymphocytes occurred exclusively in the low-FGF8/low-FGF18 group (p = 0.042). Kaplan–Meier analysis demonstrated significantly poorer survival in FGF8-high tumors (p < 0.001). Conclusions: FGF8 was associated with poorer overall survival and showed a weak inverse association with PD-L1 expression in tumor cells. FGF18 was not significantly correlated with the investigated immune-checkpoint markers. The association between combined FGF8–FGF18 expression patterns and PD-1 positivity in lymphocytes warrants further investigation.

  • Role of relaxing lateral incisions as an add-on to the difficult hiatal repair in redo and giant hernia cases

    by Ranalie Karunaratne, Christina Bergmann, Kerstin Widmann, Constantin Convalexius, Christian Günther Sebesta, Michael Kisser, Christian Sebesta, Manfred R.E. Prager


  • Open Access

    Living 20 years with perineal colostomy and dynamic graciloplasty – a case report discussing the role of this approach

    by Harald Rosen, Christian G. Sebesta, Marie Sebesta, Christian Sebesta

    Background: Despite advances in neoadjuvant therapies and surgical techniques, abdominoperineal excision of the rectum (APER) is still necessary in a considerable number of cases, often requiring the creation of a permanent colostomy, which can significantly impact a patient’s quality of life (QOL). Total anorectal reconstruction (TAR) with dynamic graciloplasty has emerged as a reconstructive option for patients undergoing APER, aiming to restore continence by avoiding a permanent abdominal colostomy and improving quality of life. However, this approach presents several challenges, including technical complexity and variable long-term outcomes. Case report: We present the case of a 34-year-old female patient who underwent APER with extended resection (rectum and vaginal wall) due to low rectal adenocarcinoma infiltrating the posterior vaginal wall. Following a prolonged postoperative course and the decision against living with an abdominal colostomy, the patient underwent secondary TAR with reconstruction of the posterior vaginal wall and dynamic graciloplasty in 2001. The procedure included creating a neorectum using a myocutaneous flap for vaginal reconstruction and a gracilis muscle wrap with neurostimulation as a neosphincter. Despite early postoperative complications, the patient achieved satisfactory continence with regular transanal irrigation and lived with the reconstruction for over 20 years. In 2024, the patient returned for management due to the obsolescence of her neurostimulator, which was subsequently removed without deterioration in her continence function. Conclusion: This case highlights the complex and prolonged management challenges associated with TAR and dynamic graciloplasty for patients with severe anorectal dysfunction following APER. While dynamic graciloplasty has been shown to offer some level of continence in patients with faecal incontinence, the need for additional interventions, such as regular irrigation, is often required to maintain quality of life after TAR following APER. The durability of this reconstructive approach and the patient’s long-term satisfaction underline its potential as a viable, though technically demanding, alternative to conventional colostomy in selected patients. However, the role of electrically induced muscle fiber transformation (“dynamic graciloplasty”) needs to be discussed.


  • Open Access

    Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic Stratification

    by Gerd Jomrich, Winny Yan, Dagmar Kollmann, Ivan Kristo, Benjamin Fallmann, Hannah Puhr, Aysegül Ilhan-Mutlu, Marlene Hollenstein, Reza Asari, Christian Sebesta, et al.

    Adenocarcinoma of the gastroesophageal junction (AEG) is an aggressive cancer with rising incidence and poor long-term survival despite multimodal treatment. Reliable preoperative prognostic markers are lacking. Methods: The study is based on data from a prospectively maintained institutional database, which was retrospectively analyzed. In total, 211 patients were analyzed who underwent curative resection for AEG to evaluate the association of SII and LVI and their combined prognostic value. Results: LVI was present in 45% of patients and was significantly associated with higher median SII values compared to patients without LVI (943 vs. 652; p < 0.001). Both high SII and the presence of LVI were independently associated with worse overall survival (p < 0.001 for both). In patients treated with primary surgery (65%), the combined presence of high SII and LVI identified a subgroup with particularly poor prognosis (pseudo-R2 increased from 0.451 to 0.524; likelihood-ratio test p < 0.001). Among patients who received neoadjuvant therapy (NT) (35%), SII remained a strong prognostic factor (pseudo-R2 = 0.432), while LVI alone was not statistically significant (p = 0.135), and its addition to the SII model did not improve prognostic performance (p = 0.377). Conclusions: The combined assessment of SII and LVI may improve prognostic stratification in AEG, especially in patients undergoing upfront surgery. These findings suggest that combined assessment of SII and LVI enhances prognostic stratification, particularly in patients treated with upfront surgery, and may aid personalized treatment and follow-up planning in AEG. To the best of our knowledge, this is the first study investigating the association of SII and LVI in AEG.


  • Top Cited Papers
    Open Access

    Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors

    by Jakob Zottl, Christian Günther Sebesta, Elena Tomosel, Marie-Christine Sebesta, Christian Sebesta

    Background: PC has become a significant global health challenge, with incidence and mortality rates rising over the past three decades. While traditionally associated with aging, recent data indicate an increasing burden among younger populations. This study aims to analyze global trends in PC incidence and mortality and to identify key contributing factors, particularly modifiable risk factors such as obesity, diabetes, and smoking. Methods: Using data from the Global Burden of Disease Study (GBD) 2021, population-based cancer registries globally and nationally, systematic reviews and analysis trends in PC incidence, mortality and survival were analyzed. To assess epidemiological shifts, we utilized previously published annual percentage change (AAPC) values stratified by region, age group, and sex, as reported in the cited literature. Additionally, the influence of modifiable risk factors was evaluated to determine their contribution to rising incidence rates. Results: Between 1990 and 2021, the global incidence of PC increased by 8.9%, from 5.47 to 5.96 per 100,000, with the highest rates observed in high-Sociodemographic-Index (SDI) regions (10.00 per 100,000) and the lowest in low-SDI regions (1.59 per 100,000). Significant increases in incidence were noted in several countries, particularly among men in Iceland (AAPC 8.85) and women in Malta (AAPC 6.04). Early-onset PC is becoming more prevalent, especially among younger women. Modifiable risk factors, including obesity, diabetes, and smoking, play a critical role, with excess body weight contributing to 17.9% of PC cases and smoking to 13.9% in the United States (U.S.). Conclusions: The rising burden of PC, particularly among younger populations, highlights the need for targeted prevention strategies, early detection efforts, and further research into the underlying mechanisms driving these trends. Addressing modifiable risk factors could be key to mitigating the increasing incidence of this highly lethal cancer.


  • Open Access

    Therapeutic Management of Gastroesophageal Reflux Disease (GERD)—Is There Something Between PPI and Fundoplication? An Overview

    by Harald Rosen, Christian Sebesta, Marie Christine Sebesta, Christian Sebesta

    Gastroesophageal reflux disease (GERD) affects millions globally, with traditional treatments like proton pump inhibitors (PPIs) and surgical fundoplication presenting challenges such as long-term medication dependency and disturbing long term side effects following surgery. This review explores emerging, alternative therapies that offer less invasive, personalized alternatives for GERD management. Endoscopic approaches, including Stretta therapy, transoral incisionless fundoplication (TIF), and endoscopic full-thickness plication (EFTP), demonstrate promising but also controversial outcomes in symptom relief and reduced acid exposure. Laparoscopic electrical stimulation therapy (EndoStim®) and the LINX® magnetic sphincter augmentation system address LES dysfunction, while endoscopic anti-reflux mucosectomy and/or ablation techniques aim to construct a sufficient acid barrier. The RefluxStop™ device offers structural solutions to GERD pathophysiology with intriguing results in initial studies. Despite promising results, further research is required to establish long-term efficacy, safety, and optimal patient selection criteria for these novel interventions. This review underscores the importance of integrating emerging therapies into a tailored, multidisciplinary approach to GERD treatment.


  • Open Access

    Unveiling New Horizons: Progress in the Management of Gastrointestinal and Hepatobiliary Cancer

    by Christian Sebesta, Harald Rosen

    The field of gastrointestinal cancer research continues to make significant strides in understanding the complexities of these challenging diseases


  • Magenkarzinom

    by Krisztina Racz, Andras Legner, Felix Böhme, Christian Sebesta


  • Top Cited Papers
    Open Access

    Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer

    by Harald Rosen, Christian G. Sebesta, Christian Sebesta

    Introduction: A total of 60–80% of patients undergoing rectal resection (mostly as a treatment for rectal cancer) suffer from a variety of partly severe functional problems despite preservation of the anal sphincter. These patients are summarized under the term low anterior resection syndrome (LARS). Preoperative radiotherapy, vascular dissection and surgical excision of the low rectum and mesorectum lead, alone or all together, to a significant impairment of colonic and (neo-) rectal motility. This results in a variety of symptoms (multiple defecation episodes, recurrent episodes of urge, clustering, incontinence, etc.) which are associated with severe impairment of quality of life (QOL). Methods: This narrative review summarizes the present state of knowledge regarding the pathophysiology of LARS as well as the evidence for the available treatment options to control the symptoms resulting from this condition. Results: A review of the literature (Medline, Pubmed) reveals a variety of treatment options available to control symptoms of LARS. Medical therapy, with or without dietary modification, shows only a modest effect. Pelvic floor rehabilitation consisting of muscle exercise techniques as well as biofeedback training has been associated with improvement in LARS scores and incontinence, albeit with limited scientific evidence. Transanal irrigation (TAI) has gained interest as a treatment modality for patients with LARS due to an increasing number of promising data from recently published studies. Despite this promising observation, open questions about still-unclear issues of TAI remain under debate. Neuromodulation has been applied in LARS only in a few studies with small numbers of patients and partly conflicting results. Conclusion: LARS is a frequent problem after sphincter-preserving rectal surgery and leads to a marked impairment of QOL. Due to the large number of patients suffering from this condition, mandatory identification, as well as treatment of affected patients, must be considered during surgical as well as oncological follow-up. The use of a standardized treatment algorithm will lead to sufficient control of symptoms and a high probability of a marked improvement in QOL.


  • Gastroenteropancreatic neuroendocrine tumors

    by Christian Sebesta, Alexandra Feichter, Flonza Selimi

    Zusammenfassung NENs stellen aufgrund ihrer Heterogenität und ihres Anspruches auf multidisziplinäre Behandlung eine Herausforderung für die Betreuung betroffener Patienten dar. Der vorliegende Artikel zielt darauf ab, einen konzisen Überblick über den aktuellen Stand in Diagnostik und Therapie zu bieten. Eine Spezifität von NENs stellt die breite Empfehlung der chirurgische Resektion von G1/G2 NENs, selbst bis in metastasierte Stadien, dar. Details zu konkreten Therapieoptionen bzw. zu den Therapien der diversen Subgruppen sind den entsprechenden Leitlinien bzw. Studien zu entnehmen. Nuklearmedizinische Möglichkeiten im Bereich der Diagnostik und Therapie bieten neue vielversprechenden Optionen, die noch weiter in Studien ergründet werden müssen.